Literature DB >> 8880004

Effects of altered prenatal hormonal environment on expression of autoimmune disease in NZB/NZW mice.

S E Walker1, L W Keisler, C W Caldwell, A B Kier, F S vom Saal.   

Abstract

F1 hybrid New Zealand Black (NZB) x New Zealand White (NZM) (NZB/NZW) mice spontaneously develop an autoimmune disease analogous to systemic lupus erythematosus (SLE). Testosterone experts a powerful suppressive effect on this disorder in adult NZB/NZW mice. A series of experiments was designed to determine if disease would also be suppressed by exposing fetal NZB/NZW mice to increased testosterone. A model was developed in which NZB dams carrying NZB/NZW fetuses were treated with testosterone in a dose adequate to masculinize the external genitalia in female fetuses. NZB/NZW mice that were derived from testosterone-treated dams and control NZB/NZW offspring were followed in a longevity study and had serial assays to assess development of SLE. Additional experiments were carried out to measure lymphocyte subsets and responses to mitogens. Results were compared with F1 hybrid offspring of C57BL/6 dams crossed with DBA/2 males, which are not autoimmune and do not develop SLE. Spleen cells from these groups were tested for Thy 1.2, CD4, CD8, and IgM receptors, and for responses to the mitogens Concanavalin A (ConA) and lipopolysaccharide. Control male NZB/NZW fetuses had unexpectedly high serum estradiol, which decreased significantly with maternal testosterone treatment. The testosterone-exposed male NZB/NZW fetuses developed into adults that lived longer than male NZB/NZW controls. Testosterone treatment of the dam was associated with elevated terminal anti-DNA levels but did not alter markers of renal diseases in adult NZB/NZW mice of either sex. Testosterone-exposed NZB/NZW females had altered T-lymphocyte subsets and testosterone-exposed males had increased response to ConA compared to controls. In male NZB/NZW fetuses whose mothers were administered testosterone, the naturally high level of circulating estradiol observed in untreated male fetuses was decreased significantly. This decrease was associated with an increase in longevity. This unique observation has important implications for fetal exposure to endocrine disruptors in the environment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880004      PMCID: PMC1469666          DOI: 10.1289/ehp.96104s4815

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  29 in total

1.  Influence of natural and synthetic estrogens on the course of autoimmune disease in the NZB-NZW mouse.

Authors:  S E Walker; G G Bole
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

Review 2.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

3.  Augmented incidence of neoplasia in NZB-NZW mice treated with long-term cyclophosphamide.

Authors:  S E Walker; G G Bole
Journal:  J Lab Clin Med       Date:  1973-10

4.  Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide.

Authors:  S E Walker; G G Bole
Journal:  Arthritis Rheum       Date:  1975 May-Jun

5.  Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats.

Authors:  M M Montano; W V Welshons; F S vom Saal
Journal:  Biol Reprod       Date:  1995-11       Impact factor: 4.285

6.  Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages.

Authors:  K A Melez; W A Boegel; A D Steinberg
Journal:  Arthritis Rheum       Date:  1980-01

7.  Approach to the study of the role of sex hormones in autoimmunity.

Authors:  A D Steinberg; K A Melez; E S Raveche; J P Reeves; W A Boegel; P A Smathers; J D Taurog; L Weinlein; M Duvic
Journal:  Arthritis Rheum       Date:  1979-11

8.  Suppressed hetergeneous antinuclear antibody response in lymphomabearing NZB/NZW mice.

Authors:  S E Walker; G G Bole
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

9.  Androgenic hormones modulate autoantibody responses and improve survival in murine lupus.

Authors:  J R Roubinian; R Papoian; N Talal
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  6 in total

1.  A female preponderance for chemically induced lupus in SJL/J mice.

Authors:  Deborah L Smith; Xin Dong; Sienmi Du; Myungshin Oh; Ram Raj Singh; Rhonda R Voskuhl
Journal:  Clin Immunol       Date:  2006-11-01       Impact factor: 3.969

2.  Asp327Asn polymorphism of sex hormone-binding globulin gene is associated with systemic lupus erythematosus incidence.

Authors:  Piotr Piotrowski; Robert Gasik; Margarita Lianeri; Dorota Cieślak; Mariusz Wudarski; Paweł Hrycaj; Jan K Łacki; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2009-08-01       Impact factor: 2.316

Review 3.  Prenatal immunotoxicant exposure and postnatal autoimmune disease.

Authors:  S D Holladay
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

Review 4.  Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure.

Authors:  S D Holladay; R J Smialowicz
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

5.  Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice.

Authors:  Catherine Sawai; Katherine Anderson; Debby Walser-Kuntz
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

Review 6.  The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?

Authors:  Lara Henze; Dorothee Schwinge; Christoph Schramm
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.